Classification of epithelial-mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis

Modern Pathology

Volumn 24, Issue 8, 2011, Pages 1060-1068

  Sung, Chang Ohk ^a   Park, Cheol Keun ^a   Kim, Seok Hyung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

carcinoma; epithelial mesenchymal transition; esophagus; phenotype; prognosis

Indexed keywords

ARTICLE; CANCER INVASION; CANCER SURVIVAL; CLINICAL FEATURE; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; NEOPLASM STAGING; PHENOTYPE; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 79961024822     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.59     Document Type: Article

References (24)

1. Thiery JP, Acloque H, Huang RY, et al. Epithelialmesenchymal transitions in development and disease. Cell 2009;139:871-890.
2. Hugo H, Ackland ML, Blick T, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007;213: 374-383. (Pubitemid 47509716)
3. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006; 66:8319-8326. (Pubitemid 44449137)
4. Lundgren K, Nordenskjold B, Landberg G. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer 2009;101: 1769-1781.
5. Usami Y, Satake S, Nakayama F, et al. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol 2008;215:330-339. (Pubitemid 351956714)
6. Cai Z, Wang Q, Zhou Y, et al. Epidermal growth factorinduced epithelial-mesenchymal transition in human esophageal carcinoma cells-a model for the study of metastasis. Cancer Lett 2010;296:88-95.
7. Isohata N, Aoyagi K, Mabuchi T, et al. Hedgehog and epithelial- mesenchymal transition signaling in normal and malignant epithelial cells of the esophagus. Int J Cancer 2009;125:1212-1221.
8. Natsugoe S, Uchikado Y, Okumura H, et al. Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep 2007;17:517-523.
9. Edge SB, Byrd DR, Compton CC, et al. American Joint Commission on Cancer Staging Manual. 7th edn. Springer: New York, 2010, pp 103-111.
10. Sinicrope FA, Ruan SB, Cleary KR, et al. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237-241.
11. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2:84-89.
12. Franz M, Spiegel K, Umbreit C, et al. Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma. Histochem Cell Biol 2009;131:651-660.
13. Jethwa P, Naqvi M, Hardy RG, et al. Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol 2008;14:1044-1052. (Pubitemid 351325004)
14. Nakanishi Y, Ochiai A, Akimoto S, et al. Oncology 1997;54:158-165.
15. Tamura S, Shiozaki H, Miyata M, et al. Decreased Ecadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus. Br J Surg 1996;83:1608-1614. (Pubitemid 26365092)
16. Inada S, Koto T, Futami K, et al. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, Ecadherin, epidermal growth factor receptor). Surg Today 1999;29:493-503. (Pubitemid 29313958)
17. Jian WG, Darnton SJ, Jenner K, et al. Expression of Ecadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance. J Clin Pathol 1997;50:640-644. (Pubitemid 27396065)
18. Pomp J, Blom J, van Krimpen C, et al. E-cadherin expression in oesophageal carcinoma treated with high-dose radiotherapy; correlation with pretreatment parameters and treatment outcome. J Cancer Res Clin Oncol 1999;125:641-645. (Pubitemid 29502346)
19. Sasaki K, Natsugoe S, Ishigami S, et al. Significance of twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2009;28:158.
20. Nair KS, Naidoo R, Chetty R. Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol 2005;58:343-351. (Pubitemid 40516162)
21. Uchikado Y, Natsugoe S, Okumura H, et al. Slug expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2005;11: 1174-1180. (Pubitemid 40175768)
22. Alves CC, Carneiro F, Hoefler H, et al. Role of the epithelial- mesenchymal transition regulator Slug in primary human cancers. Front Biosci 2009;14: 3035-3050.
23. Natsugoe S, Uchikado Y, Okumura H, et al. Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep 2007;17:517-523.
24. Turley EA, Veiseh M, Radisky DC, et al. Mechanisms of disease: epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 2008;5:280-290. (Pubitemid 351594144)